S-3 424B5 EX-FILING FEES 333-278770 0001326110 ImmunityBio, Inc. The prospectus is not a final prospectus for the related offering. 0001326110 2025-07-25 2025-07-25 0001326110 1 2025-07-25 2025-07-25 0001326110 2 2025-07-25 2025-07-25 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

ImmunityBio, Inc.

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Common Stock, $0.001 par value per share 457(r) 29,629,632 $ 2.70 $ 80,000,007.00 0.0001531 $ 12,248.01
Fees to be Paid 2 Equity Warrants for Common Stock, $0.001 parvalue per share 457(r) 29,629,632 $ 3.24 $ 96,000,008.00 0.0001531 $ 14,697.61
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 176,000,015.00

$ 26,945.62

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 26,945.62

Offering Note

1

1. Payment of the registration fee at the time of filing of the registrant's Registration Statement on Form S-3ASR (File No. 333-278770) on April 17, 2024 (the "Registration Statement") was deferred pursuant to Rules 456(b) and 457(r) under the Securities Act of 1933, as amended and is paid herewith. This "Calculation of Filing Fee" table shall be deemed to update the table in Item 14 of the Registration Statement on Form S-3.

2

See Offering Note One.